302440.KS

SK bioscience Co.,Ltd. [302440.KS] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

302440.KS Stock Summary

Top 10 Correlated ETFs

302440.KS


Top 10 Correlated Stocks

302440.KS


In the News

302440.KS Financial details

Company Rating
Buy
Market Cap
4978.43B
Income
38.93B
Revenue
369.95B
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
15 Mar 2024
P/E
134.24
Forward P/E
-
PEG
-14.99
P/S
14.14
P/B
3.03
P/C
-
P/FCF
-26.34
Quick Ratio
-
Current Ratio
7.91
Debt / Equity
-
LT Debt / Equity
0.01
-
-
EPS (TTM)
507.23
EPS next Y
-
EPS next Q
-
EPS this Y
-58.73%
EPS next Y
-
EPS next 5Y
-246.73%
EPS last 5Y
56.95%
Revenue last 5Y
38.95%
Revenue Q/Q
775.54%
EPS Q/Q
-403%
-
-
-
-
SMA20
0.97%
SMA50
-6.01%
SMA100
-8.43%
Inst Own
-
Inst Trans
-
ROA
2%
ROE
2%
ROC
0.02%
Gross Margin
46%
Oper. Margin
10%
Profit Margin
11%
Payout
-
Shs Outstand
76.83M
Shs Float
24.24M
-
-
-
-
Target Price
-
52W Range
57100.0-88600.0
52W High
-27.65%
52W Low
+12.26%
RSI
45
Rel Volume
1.16
Avg Volume
85.75K
Volume
99.74K
Perf Week
-1.69%
Perf Month
-6.01%
Perf Quarter
-13.38%
Perf Half Y
-15.77%
-
-
-
-
Beta
1.342
-
-
Volatility
304.39%, 1329.26%
Prev Close
-1.38%
Price
64100
Change
-1.38%

302440.KS Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric History 2018-12-312019-12-312020-12-312021-12-31 2022-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
43.98K3.01K3.68K12.67K7.46K
Net income per share
209.932405374.84K2K
Operating cash flow per share
7.43K588.211.96K7.32K-2.04K
Free cash flow per share
4.29K196.291.8K6.71K-3.29K
Cash per share
51.72K1.54K3.41K22.45K24.18K
Book value per share
105.12K3.81K4.31K21.84K28.44K
Tangible book value per share
94.22K3.49K4.02K21.61K28.14K
Share holders equity per share
105.12K3.81K4.31K21.84K28.44K
Interest debt per share
70.03K2.11K2.06K1.5K1.89K
Market cap
338.8B10335.34B10350.77B16495.94B4501.66B
Enterprise value
472.27B10446.03B10447.76B16504.15B4389.71B
P/E ratio
805.04704.17314.7146.4536.76
Price to sales ratio
3.8456.1945.8817.769.86
POCF ratio
22.73287.3186.130.74-36.03
PFCF ratio
39.43860.9894.0833.52-22.35
P/B Ratio
1.6144.4139.2410.32.58
PTB ratio
1.6144.4139.2410.32.58
EV to sales
5.3656.7946.3117.779.61
Enterprise value over EBITDA
21.94292.69172.0533.1626.64
EV to operating cash flow
31.69290.3986.930.76-35.13
EV to free cash flow
54.96870.294.9633.54-21.79
Earnings yield
0000.020.03
Free cash flow yield
0.0300.010.03-0.04
Debt to equity
0.650.540.460.070.07
Debt to assets
0.340.310.220.050.05
Net debt to EBITDA
6.23.11.60.02-0.68
Current ratio
2.923.751.8544.69
Interest coverage
6.285.459.09138.3846.74
Income quality
35.412.453.661.51-1.02
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.010.010.0100.01
Research and developement to revenue
0.120.150.120.050.13
Intangibles to total assets
0.050.050.030.010.01
Capex to operating cash flow
-0.42-0.67-0.08-0.080.61
Capex to revenue
-0.07-0.13-0.05-0.05-0.17
Capex to depreciation
-0.96-1.65-0.62-2.37-2.81
Stock based compensation to revenue
00000
Graham number
22.28K4.53K7.21K48.79K35.77K
ROIC
0.020.050.080.210.05
Return on tangible assets
00.040.060.170.06
Graham Net
-19.2K-468.76-218.8917.01K20.59K
Working capital
118.89B125.23B153.26B1377.85B1403.66B
Tangible asset value
188.89B213.26B245.93B1584.25B1723.52B
Net current asset value
-11.25B-504.67M35.46B1328.99B1383.46B
Invested capital
0.650.540.460.070.07
Average receivables
042.53B47.41B56.01B86.29B
Average payables
014.72B17.94B40.66B37.43B
Average inventory
034.13B53.33B102.66B161.23B
Days sales outstanding
187.0179.1788.8522.4392.29
Days payables outstanding
82.5863.2249.0564.9318.58
Days of inventory on hand
237.65125.17196.9137.41315.05
Receivables turnover
1.954.614.1116.273.95
Payables turnover
4.425.777.445.6219.64
Inventory turnover
1.542.921.852.661.16
ROE
00.060.120.220.07
Capex per share
-3.15K-391.92-166.5-606.55-1.25K

Quarterly Fundamentals Overview

Last date of statement is 2023-09-30 for Q3

Metric History 2022-09-302022-12-312023-03-312023-06-30 2023-09-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
1.19K0268.51344.730
Net income per share
2710-186-2080
Operating cash flow per share
129.580-958.46-1.35K0
Free cash flow per share
-36.510-1.05K-1.5K0
Cash per share
19.06K017.77K15.89K0
Book value per share
22.28K022.52K22.28K0
Tangible book value per share
22.04K022.27K22.03K0
Share holders equity per share
22.28K022.52K22.28K0
Interest debt per share
1.67K0840.14350.420
Market cap
6156.77B05530.71B6106.21B0
Enterprise value
6196.69B-111.95B5356.02B5888.88B0
P/E ratio
74.080-96.91-95.550
Price to sales ratio
67.620268.52230.610
POCF ratio
619.690-75.22-58.780
PFCF ratio
-2.2K0-68.46-53.080
P/B Ratio
3.603.23.570
PTB ratio
3.603.23.570
EV to sales
68.060260.04222.40
Enterprise value over EBITDA
130.0806.05K-287.70
EV to operating cash flow
623.710-72.85-56.690
EV to free cash flow
-2.21K0-66.3-51.190
Earnings yield
00000
Free cash flow yield
00-0.01-0.020
Debt to equity
0.070.070.040.020
Debt to assets
0.060.050.030.010
Net debt to EBITDA
0.840-197.3610.620
Current ratio
4.894.695.946.527.91
Interest coverage
76.7908.28-72.080
Income quality
0.4805.156.53
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.0201.460.060.19
Research and developement to revenue
0.1900.780.990
Intangibles to total assets
0.010.010.010.010
Capex to operating cash flow
-1.2800.10.11-0.13
Capex to revenue
-0.140-0.35-0.42-0.08
Capex to depreciation
-1.780-0.88-1.31-2.09
Stock based compensation to revenue
00000
Graham number
11.66K09.71K10.21K0
ROIC
0.020-0.01-0.010.03
Return on tangible assets
0.010-0.01-0.010.03
Graham Net
16.37K016.06K15.24K0
Working capital
1416.84B1403.66B1369.75B1332.8B1265.33B
Tangible asset value
1690.03B1723.52B1708.34B1692.29B1722.9B
Net current asset value
1390.25B1383.46B1352.21B1316.98B1251.34B
Invested capital
0.070.070.040.020
Average receivables
109.72B107.56B101.48B103.73B60B
Average payables
25.87B22.21B9.07B6.54B3B
Average inventory
195.05B203.75B191.73B214.7B116.68B
Days sales outstanding
98.490382.2407.860
Days payables outstanding
85.14032.3126.990
Days of inventory on hand
561.730895.131.05K0
Receivables turnover
0.9100.240.220
Payables turnover
1.0602.793.330
Inventory turnover
0.1600.10.090
ROE
0.010-0.01-0.010.03
Capex per share
-166.090-94.68-145.20

302440.KS Frequently Asked Questions

What is SK bioscience Co.,Ltd. stock symbol ?

SK bioscience Co.,Ltd. is a KR stock and trading under the symbol 302440.KS

What is SK bioscience Co.,Ltd. stock quote today ?

SK bioscience Co.,Ltd. stock price is $64100 today.

Is SK bioscience Co.,Ltd. stock public?

Yes, SK bioscience Co.,Ltd. is a publicly traded company.

Something similar

Top by Market Cap
Similar Market Cap